Search
Now showing items 1-1 of 1
After the GEMINI-ACS-1 trial
(TURKISH SOC CARDIOLOGY, 2017)
The GEMINI-ACS-1 trial has recently been published. It was designed to test whether low dose rivaroxaban as an antithrombotic agent is as safe as aspirin in patients with acute coronary syndromes (ACS). The trial is important ...